4.5 Article

Genetic variants in microRNAs and their binding sites within gene 3UTRs associate with susceptibility to age-related macular degeneration

Journal

HUMAN MUTATION
Volume 38, Issue 7, Pages 827-838

Publisher

WILEY
DOI: 10.1002/humu.23226

Keywords

Age-related macular degeneration; AMD; GWAS; microRNA; miRNA-binding site; miRNA genetic variants

Funding

  1. Glaucoomfonds
  2. Oogfonds
  3. Landelijke Stichting voor Blinden en Slechtzienden
  4. Novartis Foundation [2015-37.916.12.154]
  5. NWO grant [175.010.2005.011, 911-03-012]
  6. Iranian Ministry of health and Mashhad University of Medical Sciences
  7. Netherlands Organisation of Scientific Research NWO Investments
  8. Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]
  9. Erasmus Medical Center and Erasmus University, Rotterdam
  10. Netherlands Organization for the Health Research and Development (ZonMw)
  11. Research Institute for Diseases in the Elderly (RIDE)
  12. Ministry of Education, Culture and Science
  13. Ministry for Health, Welfare and Sports
  14. European Commission (DG XII)
  15. Municipality of Rotterdam

Ask authors/readers for more resources

Age-related macular degeneration (AMD), the leading cause of blindness in the elderly, is a complex disease that results from multiple genetic and environmental factors. MicroRNAs (miRNAs) are small noncoding RNAs that post-transcriptionally regulate target mRNAs and are frequently implicated in human diseases. Here, we investigated the association of genetic variants in miRNAs and miRNA-binding sites within gene 3-untranslated regions (3UTRs) with AMD using data from the largest AMD genome-wide association study. First, we identified three variants in miRNAs significantly associated with AMD. These include rs2168518:G>A in the miR-4513 seed sequence, rs41292412:C>T in pre-miR-122/miR-3591, and rs4351242:C>T in the terminal-loop of pre-miR-3135b. We demonstrated that these variants reduce expression levels of the mature miRNAs in vitro and pointed the target genes that may mediate downstream effects of these miRNAs in AMD. Second, we identified 54 variants (in 31 genes) in miRNA-binding sites associated with AMD. Based on stringent prioritization criteria, we highlighted the variants that are more likely to have an impact on the miRNA-target interactions. Further, we selected rs4151672:C>T within the CFB 3UTR and experimentally showed that while miR-210-5p downregulates expression of CFB, the variant decreases miR-210-5p-mediated repression of CFB. Together, our findings support the notion that miRNAs may play a role in AMD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available